PRME · Prime Medicine, Inc. · Investor Relations
$3.96
+0.13 (+3.39%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, we concluded that substantial doubt exists about our ability to continue as a going concern for 12 months from the date these condensed consolidated financial statements are issued.”View the 10-Q filed Aug 6, 2026
Market Cap
$694.67M
Shares
181.38M
Volume · Oct 20
3.64M
Avg daily vol (3M)
3.48M
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-16 | Morgan Stanley 24th Annual Global Healthcare Conference | Conference |
| 2026-09-15 | H.C. Wainwright 28th Annual Global Investment Conference | Conference |
| 2026-06-10 | Goldman Sachs 47th Annual Global Healthcare Conference | Conference |
| 2026-06-04 | Jefferies Global Healthcare Conference 2026 | Conference |
| 2026-03-11 | The Citizens Life Sciences Conference | Conference |
| 2026-03-04 | TD Cowen 46th Annual Health Care Conference | Conference |
| 2026-01-14 | 44th Annual J.P. Morgan Healthcare Conference | Conference |
| 2025-12-02 | 8th Annual Evercore Healthcare Conference | Conference |
| 2025-11-18 | Jefferies London Healthcare Conference | Conference |
| 2025-11-12 | Wilson Disease KOL Event | Event |
| 2025-10-21 | Chardan's 9th Annual Genetic Medicines Conference | Conference |
| 2025-10-14 | H.C. Wainwright Genetic Medicines Virtual Conference | Conference |
Key facts
CIK
1894562
CUSIP
74168J101
13F (30d)
12 filings
12 filers
Visit website
Investor relations